Ventyx Biosciences, Inc.VTYXNASDAQ

Revenue (LTM)

Net Income (LTM)

$-135M

+30.0% YoY

Free Cash Flow

$-131M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	0
Operating Income	-7	-67↓852.4%	-113↓68.5%	-208↓83.8%	-148↑28.6%
Net Income	-28	-84↓197.2%	-108↓29.5%	-193↓78.0%	-135↑30.0%
EBITDA	0	-84	-113↓34.7%	-207↓83.8%	-147↑29.0%
EPS Diluted	-0.56	-1.69↓201.8%	-2.06↓21.9%	-3.30↓60.2%	-1.97↑40.3%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	0	71↑28912.7%	65↓8.4%	52↓20.4%	27↓47.1%
Total Current Assets	0	263↑107255.1%	331↑25.7%	264↓20.1%	230↓13.1%
Total Assets	0	291↑118872.2%	371↑27.4%	278↓25.2%	277↓0.4%
Total Current Liabilities	1	12↑775.5%	16↑33.2%	22↑36.1%	13↓42.6%
Total Liabilities	31	12↓60.2%	18↑42.5%	34↑92.9%	23↓33.3%
Total Equity	-31	279↑1010.8%	354↑26.8%	244↓31.1%	254↑4.1%
Total Debt	13	0	2	13↑702.7%	11↓13.7%
Net Debt	12	-71↓670.8%	-63↑10.6%	-39↑38.2%	-16↑57.9%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-6	-39↓523.9%	-99↓155.6%	-167↓68.6%	-131↑21.4%
Capital Expenditure	0	-0	-0↓5.0%	-1↓86.9%	-0↑53.1%
Free Cash Flow	-6	-39↓528.1%	-99↓154.5%	-167↓68.6%	-131↑21.5%
Stock-Based Comp	0	3↑5966.7%	17↑507.0%	29↑72.5%	23↓19.8%
Net Change in Cash	-0	71↑108633.8%	-6↓108.5%	-12↓105.4%	-24↓98.3%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance